Converide Description

Converide 150 mg/12.5 mg film-coated tablets: White, round, convex, film-coated tablets with diameter 9.5 mm.
Each film-coated tablet contains 150 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
Converide 300mg/12.5mg film-coated tablets: Pink, convex, film coated capsule-shaped tablets, scored on one side, embossed "MC" on the other side, with dimensions 17.5 x 8 mm.
Each film-coated tablet contains 300 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.
Excipient with known effect: lactose monohydrate.
Converide 150 mg/12.5 mg film-coated tablets: Each film-coated tablet contains 26.65 mg of lactose (as lactose monohydrate).
Converide 300mg/12.5mg film-coated tablets: Each film-coated tablet contains 65.8 mg of lactose (as lactose monohydrate).
Excipients/Inactive Ingredients: Tablet core: Lactose Monohydrate; Pregelatinised starch; Colloidal anhydrous silica; Croscarmellose sodium E468; Cellulose microcrystalline PH-102, E460; Magnesium stearate E572.
Film-coating: Hypromellose E464, Lactose monohydrate, Magrogol 6000, Titanium dioxide E171, Red iron oxide E172 (only for the 300/12.5 mg strength).